Inventor · disambiguated record
Fiona A. Harding
Also filed as: HARDING FIONA · HARDING FIONA A
26 granted patents·37 pending applications·386 citations·filing 1998–2021
96Inventor score
Top patents by PatentIndex Score
63 records- 0196US9914783B1Anti-PD-1 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2017·Granted Mar 13, 2018·61 cites·17 claims
- 0293US6218165B1Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteinsGENENCOR INT·Filed 1999·Granted Apr 17, 2001·89 cites·10 claims
- 0392US6929939B2Proteins producing an altered immunogenic response and methods of making and using the samePROCTER & GAMBLE·Filed 2002·Granted Aug 16, 2005·38 cites·17 claims
- 0491US9079953B2Anti-VEGF antibodies and their usesHARDING FIONA A·Filed 2010·Granted Jul 14, 2015·23 cites·11 claims
- 0590US8937159B2Anti-HER2 antibodies and their usesHARDING FIONA A·Filed 2010·Granted Jan 20, 2015·12 cites·16 claims
- 0690US7476528B2Proteins producing an altered immunogenic response and methods of making and using the sameGENENCOR INT·Filed 2005·Granted Jan 13, 2009·7 cites·14 claims
- 0789US6835550B1Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteinsGENENCOR INT·Filed 1998·Granted Dec 28, 2004·67 cites·14 claims
- 0888US10040864B2Anti-OX40 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2018·Granted Aug 7, 2018·4 cites·18 claims
- 0987US9315573B2Anti-TNF-alpha antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2014·Granted Apr 19, 2016·9 cites·36 claims
- 1085US8871722B2Perhydrolase epitopesHARDING FIONA A·Filed 2006·Granted Oct 28, 2014·7 cites·3 claims
- 1182US7332320B2Protease producing an altered immunogenic response and methods of making and using the sameGENENCOR INT·Filed 2002·Granted Feb 19, 2008·11 cites·18 claims
- 1280US6936249B1Proteins producing an altered immunogenic response and methods of making and using the sameGENENCOR INT·Filed 2000·Granted Aug 30, 2005·6 cites·6 claims
- 1380US6897049B1Proteins producing an altered immunogenic response and methods of making and using the sameGENENCOR INT·Filed 2001·Granted May 24, 2005·12 cites·5 claims
- 1480US2022112304A1Anti-ox40 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1579US8088609B2CAB moleculesFOX JUDITH A·Filed 2005·Granted Jan 3, 2012·2 cites·7 claims
- 1679US6838269B1Proteins producing an altered immunogenic response and methods of making and using the sameGENENCOR INT·Filed 2000·Granted Jan 4, 2005·12 cites·12 claims
- 1776US10604584B2Anti-OX40 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2019·Granted Mar 31, 2020·0 cites·2 claims
- 1876US7329498B2HPV CD8+ T-cell epitopesGENENCOR INT·Filed 2006·Granted Feb 12, 2008·2 cites·2 claims
- 1975US2021017289A1Anti-ox40 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2074US7153659B2HPV CD8+ T-cell epitopesGENENCOR INT·Filed 2004·Granted Dec 26, 2006·11 cites·2 claims
- 2173US2020181282A1Anti-ox40 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2272US2014294881A1Proteases producing an altered immunological response and methods of making and using the sameESTELL DAVID A·Filed 2008·Application pending·0 cites
- 2371US10730953B2Anti-PD-1 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2019·Granted Aug 4, 2020·0 cites·2 claims
- 2470US10556962B2Anti-OX40 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2017·Granted Feb 11, 2020·0 cites·15 claims
- 2569US8722860B2Anti-TNF-α antibodies and their usesHARDING FIONA A·Filed 2010·Granted May 13, 2014·1 cites·36 claims
- 2667US2020317808A1Anti-pd-1 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2767US2018346593A1Anti-ox40 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2866US9279016B2Methods for identifying antibodies with reduced immunogenicityABBVIE BIOTHERAPEUTICS INC·Filed 2013·Granted Mar 8, 2016·1 cites·12 claims
- 2966US2014186922A1Proteases producing an altered immunogenic response and methods of making and using the sameDANISCO US INC·Filed 2013·Application pending·0 cites
- 3064US2013216519A1Proteases producing an altered immunogenic response and methods of making and using the sameDANISCO US INC·Filed 2013·Application pending·0 cites
- 3163US2008193976A1Pseudomonas Exotoxin A Cd4+T-Cell EpitopesHARDING FIONA A·Filed 2006·Application pending·0 cites
- 3263US2009060933A1Proteases producing an altered immunogenic response and methods of making and using the sameESTELL DAVID A·Filed 2007·Application pending·0 cites
- 3363US2020308290A1Anti-cd25 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3461US6596525B1Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteinsGENENCOR INT·Filed 1999·Granted Jul 22, 2003·10 cites·15 claims
- 3561US2009258832A1Cytokines and Cytokine Receptors With Reduced ImmunocencityPOWER SCOTT D·Filed 2009·Application pending·0 cites
- 3660US2005054843A1Proteases producing an altered immunological response and methods of making and using the sameFiled 2002·Application pending·0 cites
- 3759US2005137112A1Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteinsFiled 2004·Application pending·0 cites
- 3857US2009162917A1Subtilism Carlsberg Proteins With Reduced ImmunogencityHARDING FIONA A·Filed 2008·Application pending·0 cites
- 3957US2011076260A1Proteases Producing an Altered Immunogenic Response and Methods of Making and Using the SameESTELL DAVID A·Filed 2010·Application pending·0 cites
- 4057US2018148513A1Anti-pd-1 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4156US7879571B2Population based assessments and means to rank the relative immunogenicity of proteinsDANISCO US INC·Filed 2003·Granted Feb 1, 2011·1 cites·37 claims
- 4256US2015010539A1Anti-cd25 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4355US2013217093A1Perhydrolase epitopesDANISCO US INC·Filed 2013·Application pending·0 cites
- 4455US2015152404A1Proteases producing an altered immunological response and methods of making and using the sameDANISCO US INC·Filed 2015·Application pending·0 cites
- 4555US2011160440A1Cab MoleculesGENENCOR INT·Filed 2004·Application pending·0 cites
- 4655US2006024764A1Proteins producing an altered immunogenic response and methods of making the sameESTELL DAVID A·Filed 2004·Application pending·0 cites
- 4755US2005164257A1Proteins producing an altered immunogenic response and methods of making and using the sameFiled 2004·Application pending·0 cites
- 4854US2007037151A1Cd4+ human papillomavirus (hpv) epitopesBABE LILIA M·Filed 2004·Application pending·0 cites
- 4954US2011263517A1Cytokines and Cytokine Receptors with Reduced ImmunogenicityDANISCO US INC·Filed 2010·Application pending·0 cites
- 5051US2017233481A1Anti-cd25 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Fiona A. Harding files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →